Cartilage Repair and Joint Preservation Using PRP in Orthopedic Medicine

Articular cartilage damage presents a major challenge in orthopedic medicine due to its limited regenerative capacity. Untreated cartilage lesions often progress to osteoarthritis, leading to chronic pain and joint dysfunction. PRP therapy offers a biologically active strategy to support cartilage repair and joint preservation.

Platelet-rich plasma contains growth factors that stimulate chondrocyte proliferation, extracellular matrix synthesis, and subchondral bone signaling. When applied intra-articularly, PRP improves cartilage metabolism and reduces catabolic enzyme activity responsible for cartilage breakdown.

PRP in orthopedic cartilage treatment is particularly effective when used in early-stage cartilage degeneration or as an adjunct to surgical procedures such as microfracture or cartilage grafting. By enhancing angiogenesis and cellular signaling, PRP optimizes the regenerative environment necessary for tissue integration.

The effectiveness of PRP cartilage therapy depends on preparation quality and platelet concentration. CE Marked Class IIb PRP systems with standardized protocols and platelet counts exceeding 4 million ensure predictable biological responses and clinical safety.

PRP represents a cornerstone in modern joint preservation strategies, supporting orthopedic surgeons in delaying or preventing the progression toward joint replacement.

Keywords naturally targeted:

PRP cartilage repair, joint preservation PRP, regenerative cartilage therapy, platelet rich plasma orthopedics, PRP for joint regeneration